Byannli 700 mg is a long-acting injectable antipsychotic containing paliperidone palmitate, designed to manage schizophrenia with extended symptom control. This formulation helps reduce relapse rates and improves patient adherence by requiring fewer injections. It provides a convenient and effective treatment option, ensuring stable therapeutic effects with administration once every few months under medical supervision